MARKET

AMED

AMED

Amedisys
NASDAQ

Real-time Quotes | Nasdaq Last Sale

252.93
-2.67
-1.04%
Closed 16:01 06/11 EDT
OPEN
255.45
PREV CLOSE
255.60
HIGH
257.10
LOW
252.00
VOLUME
137.39K
TURNOVER
--
52 WEEK HIGH
325.12
52 WEEK LOW
165.42
MARKET CAP
8.24B
P/E (TTM)
41.70
1D
5D
1M
3M
1Y
5Y
Here's Why You Should Retain LHC Group (LHCG) Stock for Now
Zacks.com · 4d ago
Baxter's (BAX) Theranova-Enabled HDx Therapy Data Positive
Baxter's (BAX) Theranova-enabled HDx therapy is likely to boost clinical outcomes and lower healthcare resource utilization.
Zacks · 4d ago
Why You Should Add Veeva Systems (VEEV) to Your Portfolio
Zacks.com · 5d ago
Syneos' (SYNH) New Patient Consortium to Drive Innovation
Zacks.com · 5d ago
Amedisys Stock Appears To Be Significantly Overvalued
GuruFocus News · 6d ago
DVA vs. AMED: Which Stock Is the Better Value Option?
Zacks.com · 06/04 15:40
Insider Trends: Amedisys Insider Extends 90-Day Selling Trend
MT Newswires · 06/03 18:09
Here's Why You Should Retain PRA Health (PRAH) Stock for Now
Zacks.com · 06/01 13:08
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AMED. Analyze the recent business situations of Amedisys through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AMED stock price target is 331.92 with a high estimate of 350.00 and a low estimate of 310.00.
EPS
Institutional Holdings
Institutions: 530
Institutional Holdings: 31.88M
% Owned: 97.88%
Shares Outstanding: 32.57M
TypeInstitutionsShares
Increased
134
1.98M
New
41
374.43K
Decreased
148
2.29M
Sold Out
52
288.35K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.43%
Healthcare Providers & Services
-0.09%
Key Executives
Chairman/Chief Executive Officer/Director
Paul Kusserow
President/Chief Operating Officer
Christopher Gerard
Chief Financial Officer/Executive Vice President
Scott Ginn
Chief Human Resource Officer
Sharon Brunecz
Chief Information Officer
Michael North
Chief Compliance Officer
Denise Bohnert
Other
David Kemmerly
Lead Director/Independent Director
Richard Lechleiter
Independent Director
Vickie Capps
Independent Director
Molly Coye
Independent Director
Julie Klapstein
Independent Director
Teresa Kline
Independent Director
Bruce Perkins
Independent Director
Jeffrey Rideout
Independent Director
Ivanetta Samuels
No Data
About AMED
Amedisys, Inc. is a healthcare services company. The Company's segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. The Company owns and operates approximately 524 centers in 39 states and the District of Columbia. The Company's Home Health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The Hospice segment provides support for those who are dealing with a terminal illness, such as heart disease, pulmonary disease, Alzheimer's and Human Immunodeficiency Virus (HIV)/Acquired Immuno Deficiency Syndrome (AIDS). The Personal care segment provides patients with assistance with the essential activities of daily living.

Webull offers kinds of Amedisys Inc stock information, including NASDAQ:AMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMED stock methods without spending real money on the virtual paper trading platform.